Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Pulmatrix, Inc.PULM · Entity 8249 | Vice President, Finance | January 26, 2023 | January 30, 2023 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Pulmatrix, Inc.
Report date January 26, 2023 · Filed January 30, 2023
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $3.99 · Expires 2033-01-26 | Direct | 9,900 |
Reported balance
After 2023-01-26 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2023-01-26 · Grant · Acquired 9,900 · Balance 9,900 F1: The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 26, 2023, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 26, 2023, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 26, 2023 Filed Jan 30, 2023 21:06 UTC | Pulmatrix, Inc. PULM · Entity 8249 | GrantStock Option (Right to Buy) · Derivative | 9,900 | $0.00 Strike: $3.99 | $0.00 |
DisclosureSEC source: 0001493152-23-002921 · ownership.xml · derivative · entry 1 Siegert Michelle · CIK 0001794524 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,900 Underlying: Common Stock · 9,900 shares Expires 2033-01-26 F1 · derivative.exercise_date: The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 26, 2023, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan. Read SEC document |
| January 27, 2022 Filed Jan 29, 2022 01:40 UTC | Pulmatrix, Inc. PULM · Entity 8249 | GrantStock Option (Right to Buy) · Derivative | 184,300 | $0.00 Strike: $0.37 | $0.00 |
DisclosureSEC source: 0001493152-22-002613 · ownership.xml · derivative · entry 1 Siegert Michelle · CIK 0001794524 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 184,300 Underlying: Common Stock · 184,300 shares Expires 2032-01-27 F1 · derivative.exercise_date: The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments with the first tranche vesting on January 27, 2022, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan. Read SEC document |
| January 28, 2021 Filed Feb 2, 2021 02:45 UTC | Pulmatrix, Inc. PULM · Entity 8249 | GrantStock Option (Right to Buy) · Derivative | 91,900 | $0.00 Strike: $1.47 | $0.00 |
DisclosureSEC source: 0001493152-21-002326 · ownership.xml · derivative · entry 1 Siegert Michelle · CIK 0001794524 · Vice President, Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,900 Underlying: Common Stock · 91,900 shares Expires 2031-01-28 F1 · derivative.exercise_date: The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments beginning on the first monthly anniversary of the date of grant, with the first tranche vesting on January 28, 2021, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan. Read SEC document |
| January 09, 2020 Filed Jan 13, 2020 22:21 UTC | Pulmatrix, Inc. PULM · Entity 8249 | GrantStock Option (Right to Buy) · Derivative | 64,500 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0000899243-20-001102 · doc4.xml · derivative · entry 2 Siegert Michelle · CIK 0001794524 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,500 Underlying: Common Stock · 64,500 shares Expires 2030-01-09 F2 · derivative.exercise_date: Pursuant to the stock option agreement dated January 9, 2020, 1,343 shares underlying this stock option are fully vested and exercisable as of the date of grant. The remaining shares underlying this stock option vest and become exercisable in forty-seven (47) equal monthly installments on the 16th day of each of the 47 calendar months following the month in which the date of grant occurs, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan. Read SEC document |
| January 09, 2020 Filed Jan 13, 2020 22:21 UTC | Pulmatrix, Inc. PULM · Entity 8249 | GrantStock Option (Right to Buy) · Derivative | 154,000 | $0.00 Strike: $1.54 | $0.00 |
DisclosureSEC source: 0000899243-20-001102 · doc4.xml · derivative · entry 1 Siegert Michelle · CIK 0001794524 · Vice President of Finance 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 154,000 Underlying: Common Stock · 154,000 shares Expires 2030-01-09 F1 · derivative.exercise_date: The shares underlying this stock option will vest and become exercisable in forty-eight (48) equal monthly installments beginning on the first monthly anniversary of the date of grant, with the first tranche vesting on January 9, 2020, provided that the reporting person is providing services to the Issuer on the applicable vesting date and subject to the terms and conditions of the Pulmatrix, Inc. Amended and Restated 2013 Employee, Director and Consultant Equity Incentive Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.